BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29629667)

  • 21. Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agents.
    Kamal A; Ramakrishna G; Lakshma Nayak V; Raju P; Subba Rao AV; Viswanath A; Vishnuvardhan MV; Ramakrishna S; Srinivas G
    Bioorg Med Chem; 2012 Jan; 20(2):789-800. PubMed ID: 22209733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrrolizines: Promising scaffolds for anticancer drugs.
    Belal A; El-Gendy Bel-D
    Bioorg Med Chem; 2014 Jan; 22(1):46-53. PubMed ID: 24331756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Evaluation of Cytotoxic Activity of Some Pyrroles and Fused Pyrroles.
    Fatahala SS; Mohamed MS; Youns M; Abd-El Hameed RH
    Anticancer Agents Med Chem; 2017; 17(7):1014-1025. PubMed ID: 28042776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybridized Quinoline Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and Molecular Docking.
    Selim MR; Zahran MA; Belal A; Abusaif MS; Shedid SA; Mehany ABM; Elhagali GAM; Ammar YA
    Anticancer Agents Med Chem; 2019; 19(4):439-452. PubMed ID: 30417798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
    Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
    Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of chemical space based on a pyrrolo[1,2-a]pyrazine core: Synthesis and its anticancer activity in prostate cancer and breast cancer cells.
    Seo Y; Lee JH; Park SH; Namkung W; Kim I
    Eur J Med Chem; 2020 Feb; 188():111988. PubMed ID: 31901746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors.
    Türe A; Kahraman DC; Cetin-Atalay R; Helvacıoğlu S; Charehsaz M; Küçükgüzel İ
    Comput Biol Chem; 2019 Feb; 78():227-241. PubMed ID: 30579980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
    Ahmed NM; Youns M; Soltan MK; Said AM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
    Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
    Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents.
    Eldehna WM; Hassan GS; Al-Rashood ST; Al-Warhi T; Altyar AE; Alkahtani HM; Almehizia AA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):322-332. PubMed ID: 30722708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
    Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
    Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
    Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptotic induction mediated p53 mechanism and Caspase-3 activity by novel promising cyanoacrylamide derivatives in breast carcinoma.
    Mohamed MF; Samir N; Ali A; Ahmed N; Ali Y; Aref S; Hossam O; Mohamed MS; Abdelmoniem AM; Abdelhamid IA
    Bioorg Chem; 2017 Aug; 73():43-52. PubMed ID: 28601699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents.
    Labib MB; Philoppes JN; Lamie PF; Ahmed ER
    Bioorg Chem; 2018 Feb; 76():67-80. PubMed ID: 29153588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
    Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
    Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
    Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
    Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of Novel Heterocyclic-Based 4
    Alblewi FF; Okasha RM; Eskandrani AA; Afifi TH; Mohamed HM; Halawa AH; Fouda AM; Al-Dies AM; Mora A; El-Agrody AM
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30889862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Characterization, and Anticancer Activity of Novel Lipophilic Emodin Cationic Derivatives.
    Yang X; Zhao W; Hu X; Hao X; Hong F; Wang J; Xiang L; Zhu Y; Yuan Y; Ho RJ; Wang W; Shao J
    Chem Biol Drug Des; 2015 Dec; 86(6):1451-7. PubMed ID: 26108260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.